/content/dam/www/people-profile-photos/f/mary-flowers/mary-flowers-d.jpg
/content/dam/www/people-profile-photos/f/mary-flowers/provider-mary-flowers-directory-2x.jpg
Flowers
Mary Flowers, MD
- Professor Emeritus, Clinical Research Division, Fred Hutch
- Professor, Division of Hematology and Oncology, Department of Medicine, University of Washington
Background
Dr. Mary Flowers is a world-renowned expert in the study and treatment of chronic graft-vs-host disease, or cGVHD, a complication of transplantation in which the donated stem cells attack the recipient's healthy tissues. Dr. Flowers helps transplant survivors and their primary care physicians manage post-treatment complications as patients recover and resume their lives. In addition to her GVHD research, Dr. Flowers studies the effectiveness of using donated lymphocytes, a type of immune cell, to treat recurrent malignancies after transplantation with donated cells.
Director at Large, American Society for Transplantation and Cellular Therapy (ASTCT) Executive Committee
Co-Chair, Brazil/Seattle Chronic GVHD Consortium
Co-Chair, Brazilian Society of BMT Chronic GVHD and Late Effects Working Group
Co-Chair, National Institute of Health (NIH) Chronic GVHD Diagnosis and Staging Working Group
Co-Chair, Center for International Blood & Marrow Transplant Research (CIBMTR) Working Committee for Late Effects and Quality of Life
Co-Chair, ASTCT and CIBMTR Scientific Organizing Committee
Education
MD, Centro de Ciencias da Saude da Universadiade Federal do Rio Grande do Norte, Natal, R.N., Brasil
Board Certified in Hematology, Pontifícia Universidade Catolica do Rio de Janeiro, Rio de Janeiro, R.J., Brazil
Clinical Expertise
Management of chronic GVHD and other late effects of hematopoietic cell transplantation.
Research Interests
Dr. Flowers’ clinical research has focused on long-term outcomes after hematopoietic cell transplantation (HCT), with particular attention to studies of chronic graft-versus-host disease (GVHD), quality of life and other late events. Her research has spanned the gamut from clinical trials to registry studies to cohort studies. She has been the principal investigator or co-investigator in several interventional clinical trials including multicenter randomized studies in chronic GVHD.